Keywords: codexis, lonza, commercialize, novel, chiral, process, firm

Codexis and Lonza commercialize novel chiral process

Article | 02 August 2004

Print This

US firm Codexis and Switzerland's Lonza say they have commercialized anovel process for the synthesis of a key chiral pharmaceutical ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in